A Study Of ICU Web Application To Improve Communication, Humanization And Engagement During Critical Illness

Overview

About this study

The purpose of this study is to identify, refine, and reach stakeholder consensus on the most important SmartICU features through a structured modified Delphi process.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years

  • Clinicians, providers, or allied health stakeholders who are affiliated with ICU

  • Able to read and complete English-language surveys

  • Stakeholder role relevant to ICU or digital health engagement

  • Able to provide consent electronically

  • (Phase 2) Patients and family members from the medical ICU who have stayed more than 72 hours in the ICU

Exclusion Criteria:

  • Age < 18

  • Unwilling/unable to complete Delphi rounds

  • Non-English speaking (translation planned in future phases)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/27/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sumera Ahmad, M.B.B.S.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions